Published in Cancer Weekly, April 12th, 2005
In connection with the company's preparation of its consolidated financial statements for 2004 and the audit of those financial statements, the audit committee of the board of directors is conducting a review, with the assistance of management, of the company's revenue recognition policies and accounting for product sales, including its estimates of product returns under SFAS 48, "Revenue Recognition when Right of Return Exists" and question 9 of SAB No. 101 -"Revenue Recognition in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.